Publication Cover
Orbit
The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery
Volume 42, 2023 - Issue 5
119
Views
2
CrossRef citations to date
0
Altmetric
Original Investigation

Morphological features of regenerative processes after dacryocystorinostomy with the use of mitomycin C

, , , & ORCID Icon
Pages 496-501 | Received 10 Jul 2022, Accepted 06 Oct 2022, Published online: 20 Oct 2022

References

  • Follonier L, Schaub S, Meister JJ, Hinz B. Myofibroblast communication is controlled by intercellular mechanical coupling. J Cell Sci. 2008;121(20):3305–3316. 2008/10/02. doi:10.1242/jcs.024521.
  • Ugurbas SH, Zileliogiu G. Dacryocystorhinostomy with intraoperative mitomycin C. Ophthalmology. 1998;105(1):4. 1998/01/27. doi:10.1016/s0161-6420(98)90392-x.
  • Ugurbas SH, Zilelioglu G, Sargon MF, Anadolu Y, Akiner M, Akturk T. Histopathologic effects of mitomycin-C on endoscopic transnasal dacryocystorhinostomy. Ophthalmic Surg Lasers. 1997;28(4):300–304. 1997/04/01. doi:10.3928/1542-8877-19970401-07.
  • Vinciguerra A, Nonis A, Resti AG, Bussi M, Trimarchi M. Impact of post-surgical therapies on endoscopic and external dacryocystorhinostomy: systematic review and meta-analysis. Am J Rhinol Allergy. 2020;34(6):846–856. 2020/07/25. doi:10.1177/1945892420945218.
  • Kamal S, Ali MJ, Naik MN. Circumostial injection of mitomycin C (COS-MMC) in external and endoscopic dacryocystorhinostomy: efficacy, safety profile, and outcomes. Ophthalmic Plast Reconstr Surg. 2014;30(2):187–190. 2014/03/13. doi:10.1097/IOP.0000000000000102.
  • Nemet AY, Wilcsek G, Francis IC. Endoscopic dacryocystorhinostomy with adjunctive mitomycin C for canalicular obstruction. Orbit. 2007;26(2):97–100. 2007/07/07. doi:10.1080/01676830601174627.
  • Do JR, Lee H, Baek S, Lee TS, Chang M. Efficacy of postoperative mitomycin-C eye drops on the clinical outcome in endoscopic dacryocystorhinostomy. Graefes Arch Clin Exp Ophthalmol. 2016;254(4):785–790. 2015/12/10. doi:10.1007/s00417-015-3229-2.
  • Atkova EL, Fedorov AA, Root AO, Iartsev SD, Krakhovetsky NN, Yartsev VD. Causes of unsatisfactory results of the use of mitomycin-C in endoscopic endonasal dacryocystorhinostomy. Saudi J Ophthalmol. 2017;31(3):150–155. 2017/09/02. doi:10.1016/j.sjopt.2017.05.007.
  • Phelps PO, Abariga SA, Cowling BJ, Selva D, Marcet MM. Antimetabolites as an adjunct to dacryocystorhinostomy for nasolacrimal duct obstruction. Cochrane Database Syst Rev. 2020;4(4):CD012309. 2020/04/08. doi:10.1002/14651858.CD012309.pub2.
  • Wormald PJ. Powered endoscopic dacryocystorhinostomy. Otolaryngol Clin North Am. 2006;39(3):539–549, ix. 2006/06/08. doi:10.1016/j.otc.2006.01.009.
  • At’Kova EL, Ramenskaya GV, Root AO, Krakhovetskiy NN, Yartsev VD, Yartsev SD, et al. Mitomycin C after endoscopic endonasal dacryocystorhinostomy. Vestn Oftalmol. 2017/11/23. 2017;133(5):16–23. doi:10.17116/oftalma2017133516-22.
  • At’Kova EL, Fedorov AA, Root AO, Krakhovetskiy NN, Yartsev VD, Reyn DA, et al. Morphological analysis of reparative process at osteotomy site after endoscopic endonasal dacryocystorhinostomy. Vestn Oftalmol. 2017/01/26. 2016;132(6):87–92. doi:10.17116/oftalma2016132687-92.
  • Heindl LM, Junemann A, Holbach LM. A clinicopathologic study of nasal mucosa in 350 patients with external dacryocystorhinostomy. Orbit. 2009;28(1):7–11. 2009/02/21. doi:10.1080/01676830802414806.
  • Smirnov G, Pirinen R, Tuomilehto H, Seppa J, Terasvirta M, Uusitalo H, et al. Strong expression of HSP47 in metaplastic nasal mucosa may predict a poor outcome after primary endoscopic dacryocystorhinostomy: a prospective study. Acta Ophthalmol. 2009/09/30. 2011;89(2):e132–136. doi:10.1111/j.1755-3768.2009.01654.x.
  • Penttila E, Hyttinen JM, Hytti M, Kauppinen A, Smirnov G, Tuomilehto H, et al., 2014/05/23. Upregulation of inflammatory genes in the nasal mucosa of patients undergoing endonasal dacryocystorhinostomy. Clin Ophthalmol. 2014;8:799–805. doi:10.2147/OPTH.S50195.
  • Yartsev V, Gabashvili A, Atkova E, Melnikov P, Nesterova T. Study of dosage-dependent effects of cytostatic drugs using a fibroblast cell culture of the human nasal mucosa. Int Arch Otorhinolaryngol. 2020;24(02):e206–210. 2020/04/08. doi:10.1055/s-0039-1697996.
  • Kumar V, Ali MJ, Ramachandran C. Effect of mitomycin-C on contraction and migration of human nasal mucosa fibroblasts: implications in dacryocystorhinostomy. Br J Ophthalmol. 2015;99(9):1295–1300. 2015/06/11. doi:10.1136/bjophthalmol-2014-306516.
  • Ali MJ, Baig F, Lakshman M, Naik MN. Electron microscopic features of nasal mucosa treated with topical and circumostial injection of mitomycin C: implications in dacryocystorhinostomy. Ophthalmic Plast Reconstr Surg. 2015;31(2):103–107. 2014/06/05. doi:10.1097/IOP.0000000000000205.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.